Wire Stories
-
361Pharmatech Associates’ Board of Directors Appoints Sireesha Yadlapalli as Chief Executive Officer
HAYWARD, Calif.–(BUSINESS WIRE)–#BigPharma—The Board of Directors of Pharmatech Associates today announced the appointment of Sireesha Yadlapalli as chief executive officer, effective June...
-
388PowerVia Test Shows Industry-Leading Performance
Intel is first to implement backside power in a product-like chip, resulting in over 90% cell utilization and other gains SANTA CLARA,...
-
482Wipro VisionEDGE to Power Bowling Center TV’s New Digital Out-of-Home Network
The cloud-based dynamic digital signage solution will enhance consumer experience and drive advertising revenue EAST BRUNSWICK, N.J. & BENGALURU, India–(BUSINESS WIRE)–$WIPRO #BCTV–Wipro...
-
404Odyssey Marine Exploration Announces Partnership with Ocean Minerals LLC for a New Cook Islands Exploration Project
TAMPA, Fla.–(BUSINESS WIRE)–$OMEX–Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), a global subsea mineral exploration, validation, and development company, announced today an important next...
-
450Beyond Music Announces Successful $170M Strategic Fundraising Round
Asia’s largest music IP investment firm secures new capital to expand business in South Korea and beyond SEOUL, South Korea–(BUSINESS WIRE)–Beyond Music,...
-
412ENHERTU® Demonstrated Clinically Meaningful and Durable Responses in Patients Across Multiple HER2 Expressing Advanced Solid Tumors
Daiichi Sankyo and AstraZeneca’s ENHERTU showed an objective response rate of 37.1% in the overall population of the DESTINY-PanTumor02 phase 2 trial...
-
421ZCG-Backed Unimed to Expand Operations into Singapore with Marine Pharma Merger
Leading Global Provider of Pharmaceutical and Medical Solutions to the Maritime Industry Establishes Distribution Center in Top Hub for International Shipping Integrates...
-
479Vaxxas Appoints Rochelle Chaiken, M.D., as Chief Medical Officer
Industry veteran and senior medical leader from Pfizer brings deep global expertise as Vaxxas advances multiple clinical programs and moves toward commercialization....
-
400Vaxxas Announces Interim Results from Phase I Clinical Study of First Needle-Free COVID-19 Vaccine Delivered Using Proprietary High-Density Microarray Patch (HD-MAP)
Encouraging interim results from Phase 1 human clinical trial show COVID-19 vaccine candidate, called HexaPro, to be safe and well tolerated with...
-
423Basgenbio to Present at the BIO International Convention 2023
SEOUL, South Korea–(BUSINESS WIRE)–#BIOInternationalConvention—Basgenbio Inc., a clinico-genomic cohort data-based R&D company, has announced that the company will be presenting at the BIO...
